Acute Lymphoblastic Leukemia: Challenges in MRD Testing
2 Visninger
• 08/04/23
0
0
Indlejre
administrator
Abonnenter
Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer